Drug Shortage Report for TARO-CARBAMAZEPINE

Last updated on 2022-12-12 History
Report ID 31631
Drug Identification Number 02407515
Brand name TARO-CARBAMAZEPINE
Common or Proper name TARO CARBAMAZEPINE
Company Name TARO PHARMACEUTICALS INC
Market Status DORMANT
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500's
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-29
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-12-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v76 2022-12-12 French Compare
v75 2022-12-12 English Compare
v74 2022-11-24 French Compare
v73 2022-11-24 English Compare
v72 2022-11-15 French Compare
v71 2022-11-15 English Compare
v70 2022-11-03 French Compare
v69 2022-11-03 English Compare
v68 2022-09-16 French Compare
v67 2022-09-16 English Compare
v66 2022-08-25 French Compare
v65 2022-08-25 English Compare
v64 2022-04-12 French Compare
v63 2022-04-12 English Compare
v62 2022-01-06 French Compare
v61 2022-01-06 English Compare
v60 2021-12-07 French Compare
v59 2021-12-07 English Compare
v58 2021-11-26 French Compare
v57 2021-11-26 English Compare

Showing 1 to 20 of 76